制度・支援
指定難病 — No.194

ソトス症候群

検索語 Sotos Syndrome ・ 最終更新 2026-07-21 19:19 ・ 最新に更新

Data Sheet
指定 No.194
Src PubMed · CT.gov · jRCT

これは医療アドバイスではありません。診断・治療の判断は必ず主治医にご相談ください。論文や治験は「今わかっている研究の状況」を示すもので、効果を保証するものではありません。

( 01 )EVIDENCE / PUBMED · 5件

世界の論文

直近の研究を、やさしい日本語で

各論文の見出しにある「確からしさ」は、その研究がどれくらい信頼できるかの目安です。「理論段階」はまだ仮説に近く、下にいくほど多くの患者で検証されていて、「メタ解析」がもっとも信頼できます。

不明
MK-01 · PMID 42311909

Correction: Beyond the known phenotype of sotos syndrome: a 31-individuals cohort study

Abstract / 原文

[This corrects the article DOI: 10.3389/fped.2023.1184529.].

Journal
Frontiers in pediatrics(2026)
Authors
9名
Type
Published Erratum
PubMedで原文を見る
不明
MK-02 · PMID 42311878

A Case of Malan Syndrome With Pulmonary Artery Dilatation due to a Novel Frameshift Variant in Exon 2 of the NFIX Gene

Abstract / 原文

Malan syndrome is a rare overgrowth disorder caused by deletions or pathogenic variants in the NFIX gene. Here, we present the case of a Japanese male infant with Malan syndrome, which was caused by a novel frameshift variant resulting from an eight-base insertion in Exon 2 of the NFIX gene. Echocardiography revealed dilatation of the pulmonary artery without hemodynamic abnormalities. Malan syndrome shares many clinical features with Sotos syndrome, including overgrowth, macrocephaly, developmental delay, and intellectual disability. Therefore, molecular genetic testing is required for diagnosis. Pathogenic variants in the NFIX gene have also been reported in individuals with Marshall-Smith syndrome. Some individuals exhibit phenotypic overlap between Malan syndrome and Marshall-Smith syndrome. Our patient was diagnosed with Malan syndrome because he had a frameshift variant in Exon 2, resulting in haploinsufficiency, and exhibited macrocephaly, but not proptosis or micrognathia. To our knowledge, this is the second reported case in the literature of concomitant pulmonary artery dilatation in Malan syndrome.

Journal
Case reports in genetics(2026)
Authors
5名
Type
Journal Article
PubMedで原文を見る
不明
MK-03 · PMID 42286513

Clinical characterization and developmental follow-up of a child with Sotos syndrome carrying a novel NSD1 variant

Abstract / 原文

BACKGROUND: Sotos syndrome is a rare overgrowth-intellectual disability(OGID) disorder typically associated with developmental delay that stabilizes or improves with early intervention. CASE PRESENTATION: We report a 17-month-old boy with classic clinical features of Sotos syndrome who presented with severe speech and motor delay. Whole-exome sequencing(WES) revealed a novel de novo nonsense pathogenic variant in NSD1:c.3910 C > T (p.Gln1304Ter), which is predicted to truncate multiple functional domains, including the SET(Su(var)3-9, Enhancer-of-zeste, and Trithorax) catalytic domain. Despite early and continuous rehabilitation, his developmental quotient(DQ) decreased from 45.8 at 17 months to 39.9 at 28 months, indicating slow and limited developmental progress over time. Brain MRI (magnetic resonance imaging) revealed corpus callosum abnormalities and reduced white matter volume. CONCLUSIONS: This is the first report of Sotos syndrome caused by the NSD1:c.3910 C > T (p.Gln1304Ter) pathogenic variant. Beyond expanding the spectrum of pathogenic variants, this case highlights a relatively severe neurodevelopmental profile with persistently limited progress, underscoring the importance of early genetic diagnosis, sustained multidisciplinary rehabilitation, and long-term follow-up to optimize outcomes in affected children.

Journal
BMC pediatrics(2026 Jun)
Authors
8名
Type
Journal Article
PubMedで原文を見る
症例報告
MK-04 · PMID 42256690

[Oral rehabilitation in Sotos syndrome: case report and scoping review of the literature]

Abstract / 原文

Sotos syndrome (SS) is a rare genetic disorder characterized by overgrowth, distinctive facial features, and dentofacial abnormalities. While its oral manifestations are well documented in childhood, there is limited evidence regarding dental management in adults. This case report, prepared in accordance with the CARE guidelines, describes a 28-year-old woman diagnosed with SS who presented with typical craniofacial features of the condition. The patient sought care for partial edentulism, and oral rehabilitation with removable partial dentures was planned. The treatment approach considered the anatomical, functional, and cognitive limitations associated with the syndrome, and included a preventive phase, progressive prosthetic adaptation, and periodic clinical follow-ups. After four months, the patient showed satisfactory prosthetic adaptation, functional stability, and good oral hygiene. A scoping review of the literature was conducted following PRISMA-ScR guidelines. Searches were performed in the PubMed and Web of Science databases to identify studies reporting dental treatments in patients with a confirmed diagnosis of SS. Six case reports published between 2006 and 2023 were included. The most frequently reported oral manifestations were severe malocclusions, hypodontia, supernumerary teeth, and skeletal abnormalities. Management was interdisciplinary, with a focus on orthodontic therapies in younger patients and implant-supported rehabilitations in adults. Removable prosthetic rehabilitation represents a valid and effective alternative for adults with SS, particularly when implant-based treatments are contraindicated. This case contributes new clinical evidence and highlights the importance of personalized approaches and continuous follow-up in this patient population.

Journal
Revista cientifica odontologica (Universidad Cientifica del Sur)(2026)
Authors
3名
Type
Case Reports, English Abstract, Journal Article
PubMedで原文を見る
観察研究
MK-05 · PMID 42216215

Co-occurrence of acute leukemia and type 1 diabetes among children: a caseseries

Abstract / 原文

BACKGROUND: Leukemia is the most common malignancy in children, while type 1 diabetes mellitus (T1DM) is one of the most prevalent autoimmune diseases among children. The etiology of both conditions is still largely unexplained, yet emerging evidence suggests certain similarities in environmental exposures and genetic predispositions. In this case-series, we sought a new potential factor behind the co-occurrence of leukemia and T1DM by thoroughly reviewing the medical records of patients diagnosed with both diseases. METHODS: We conducted a retrospective case series at Tampere University Hospital, Finland, by identifying pediatric patients diagnosed with both acute leukemia and T1DM from 1990 to 2023 using (International Classification of Diseases-10th revision) ICD-10 codes. Clinical and laboratory data, including leukemia subtype, age at diagnosis, treatments, comorbidities, and medical history, were collected, reviewed and analyzed descriptively. Study protocol was locally approved, and patient health data privacy was respected. RESULTS: Among 12 initially identified cases, seven met the inclusion criteria. Five cases were diagnosed with B-cell acute lymphoblastic leukemia (B-ALL), one with T-cell ALL (T-ALL), and one with acute myeloid leukemia. The mean age at leukemia diagnosis was 8.7 years (range from 0.7 to 15.3), while the mean age at T1DM diagnosis was 11.8 years (range from 7.5 to 17.8). In five cases, leukemia preceded T1DM, with two cases linked to asparaginase-induced pancreatitis. In two cases, T1DM developed before leukemia. Additional comorbidities included Down syndrome, Sotos syndrome, celiac disease, epilepsy, and Sweet's syndrome. CONCLUSION: This case-series presents findings, which align with previous observations (e.g., Down syndrome, pancreatitis), though a less often reported finding, Sotos syndrome, was also observed.

Journal
Journal of medical case reports(2026 May)
Authors
4名
Type
Journal Article
PubMedで原文を見る
( 02 )TRIALS / JAPAN · 0件

日本で参加できる治験

現在 募集中のもの

日本で現在募集中の治験は見つかりませんでした。下の公式レジストリで条件を変えると見つかる場合があります。
( 03 )REGISTRY / jRCT

治験をもっと探す

日本の公式レジストリで全件を確認

上の一覧は ClinicalTrials.gov の一部です。日本国内の治験の多くは、日本の公式レジストリ jRCT にのみ登録されています。下記から最新の全件をご確認ください。

※ jRCTは自動の大量データ取得を禁じているため、本サービスはjRCTを自動収集せず、患者ご自身が公式サイトで検索できるリンクでご案内しています(規約順守)。

お金・介護・制度ソトス症候群の療養に使えるかもしれない公的サポートを調べる医療費・生活費・介護の支援制度と相談先を、あなたの状況に合わせてご案内(回答は端末内で完結)
( 04 )SUPPORT

患者会・相談窓口

一人で抱え込まないでください

同じ病気の患者・家族とつながる、制度や生活の相談をする、といったときの窓口です。

全国の相談先

※ お住まいの都道府県の「難病相談支援センター」でも、医療費助成や療養生活の相談ができます(難病情報センターから探せます)。